YTHDF1 promotes the malignant phenotype of HCC by activating AKT/glycogen synthase kinase (GSK)/3β/β-catenin signaling and promoting EMT (Bian et al., 2020). Here, YTHDF1 is linked to hepatocellular carcinoma.